• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Humana Expands Cancer Care for Medicare Advantage Members Through Atlas Oncology Partnership

    1/13/26 8:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care
    Get the next $HUM alert in real time by email
    • Eligible Humana Medicare Advantage members in Tennessee and Mississippi now have access to Atlas Oncology Partners' coordinated oncology care model.
    • The program integrates interdisciplinary care teams, including oncologists, nurses, social workers and patient navigators, to coordinate cancer treatment and supportive care.
    • Expanded clinical and supportive services aim to reduce gaps in care, improve quality of life, and help patients avoid unnecessary emergency or urgent care visits.

     

    Leading health and well-being company Humana Inc. (NYSE:HUM) today announced it is entering into a partnership with Atlas Oncology Partners to make cancer care simpler, more supportive and focused on improving patients' quality of life.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260113852974/en/

    Humana's partnership with Atlas Oncology is designed to make care simpler and more connected -- bringing together doctors, nurses, patient navigators, social works and other specialist to support patients every step of the way.

    Humana's partnership with Atlas Oncology is designed to make care simpler and more connected -- bringing together doctors, nurses, patient navigators, social works and other specialist to support patients every step of the way.

    Cancer care often means seeing several doctors and making frequent visits, which can feel overwhelming for patients and providers alike. For Medicare beneficiaries, this can lead to gaps in care and important needs being overlooked. Humana's partnership with Atlas Oncology is designed to make care simpler and more connected – bringing together doctors, nurses, patient navigators, social workers and other specialists to support patients every step of the way, including virtual urgent care and palliative care when needed.

    "Patients often feel overwhelmed from the moment they hear the words ‘you have cancer.' When care isn't connected, it can create unnecessary hurdles at an already difficult time. A coordinated team guiding them at every step helps to ease the burden," said Oraida Roman, Humana's Senior Vice President of National Provider Strategies and Operations. "Coordinated, holistic care is core to Humana's leadership in value-based care. By integrating care teams and resources, we're helping patients get the right care at the right time, improving quality of life and reducing barriers."

    How the Atlas Oncology Care Model Works

    Humana Medicare Advantage members who are eligible for this program in Tennessee and Mississippi have access to the Atlas care model services as of Jan. 1, 2026. These services and resources include:

    • Embedded, holistic patient support. A local interdisciplinary care team managed by Atlas delivers additional high value wrap-around services to patients, in partnership with providers.
    • Cancer-Adjacent Condition Management. On-site and virtual clinical support for patients navigating medical conditions that can negatively affect their health but often go under addressed during a cancer diagnosis.
    • Care Coordination and Psychosocial Support. Proactive screening, care coordination, social work, and counseling to address barriers to care and provide high levels of patient satisfaction and engagement.
    • Expanded Patient Access to Clinical Support. Real-time support so patients never feel alone. Same-day or next-day appointments with in-person and virtual resources to help reduce avoidable emergency room or urgent care visits.
    • Integrated communication between clinicians. Proactive communication with cancer patients enables a comprehensive care plan that addresses clinical and quality of life needs. Atlas ensures oncology teams, other specialists, and PCPs have real-time updates, enabling proactive, collaborative care planning.
    • Advanced supportive care. Advanced clinical practitioners provide in-person resources focused on optimizing quality of life, clarifying goals of care, and ensuring patients' values and preferences are central to treatment decision-making.

    "Our mission is to empower oncology practices with resources and support that impact patient quality of life and outcomes," said Kate Barnard Roberts, President and Co-Founder at Atlas. "We are proud to partner with Humana as they expand value-based care into oncology and deliver embedded, coordinated, and comprehensive support for seniors throughout their cancer journey."

    Other providers are available in the Humana network. Provider may also contract with other plan sponsors.

    About Humana

    Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

    About Atlas Oncology Partners

    Atlas Oncology Partners is dedicated to delivering uplifting and responsive cancer care during and beyond treatment. By partnering with leading oncologists and taking full medical cost risk, Atlas offers an innovative solution that delivers better care experiences while easing the economic strain of cancer treatment. Learn more at www.atlasoncpartners.com

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260113852974/en/

    Humana Media Contact:

    Cait Crenshaw Whatley

    Humana Corporate Communications

    cwhatley@humana.com

    Atlas Oncology Media Contact:

    Emma Nosseir

    Chief of Staff, Atlas Oncology Partners

    info@atlasoncpartners.com

    Get the next $HUM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HUM

    DatePrice TargetRatingAnalyst
    2/2/2026$174.00Equal-Weight → Underweight
    Morgan Stanley
    1/7/2026$290.00Overweight → Equal Weight
    Wells Fargo
    12/5/2025$313.00Hold → Buy
    Jefferies
    10/14/2025$235.00Sell
    Goldman
    9/22/2025$295.00In-line
    Evercore ISI
    5/1/2025$315.00Mkt Perform → Outperform
    Raymond James
    11/6/2024$247.00 → $308.00Underperform → Neutral
    BofA Securities
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $HUM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Humana downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Humana from Equal-Weight to Underweight and set a new price target of $174.00

    2/2/26 6:49:06 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Humana from Overweight to Equal Weight and set a new price target of $290.00

    1/7/26 8:56:48 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana upgraded by Jefferies with a new price target

    Jefferies upgraded Humana from Hold to Buy and set a new price target of $313.00

    12/5/25 8:31:42 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    SEC Filings

    View All

    Humana Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HUMANA INC (0000049071) (Filer)

    2/11/26 6:40:24 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form S-8 POS filed by Humana Inc.

    S-8 POS - HUMANA INC (0000049071) (Filer)

    12/19/25 4:57:12 PM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HUMANA INC (0000049071) (Filer)

    12/16/25 8:05:45 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Martin Aaron claimed no ownership of stock in the company (SEC Form 3)

    3 - HUMANA INC (0000049071) (Issuer)

    1/27/26 9:30:40 AM ET
    $HUM
    Medical Specialities
    Health Care

    President & CEO Rechtin James A. converted options into 2,183 units of Humana Common and covered exercise/tax liability with 980 units of Humana Common (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    1/12/26 9:42:43 AM ET
    $HUM
    Medical Specialities
    Health Care

    Director Feinberg David T was granted 766 units of Humana Common, increasing direct ownership by 174% to 1,207 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    1/5/26 2:29:49 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Humana Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Financial Guidance

    Reports 4Q25 net loss per share of $6.61 on a GAAP basis, Adjusted net loss per share of $3.96; reports full year (FY) 2025 earnings per share (EPS) of $9.84 on a GAAP basis, $17.14 on an Adjusted basis; quarterly and FY Adjusted results in line with management's expectations 4Q25 Insurance segment GAAP benefit ratio of 93.1 percent; FY 2025 Insurance segment GAAP benefit ratio of 90.4 percent, slightly better than guidance of 'the top end of the range of 90.1 percent to 90.5 percent' Introduces FY 2026 GAAP EPS guidance of 'at least $8.89'; 'at least $9.00' on an Adjusted basis; the anticipated year-over-year decline results from the Star Ratings headwind for Bonus Year 2026, net of

    2/11/26 6:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Named KCTCS Education First Employer, Announces Humana Scholars Program for Nursing Students

    Humana is investing in a new program with Jefferson Community and Technical College to strengthen and support Kentucky's nursing workforce. In announcing the launch of the Humana Scholars program, Humana joins the Kentucky Community and Technical College System (KCTCS) network of Education First Employers, partnering with the system's Louisville campus, Jefferson. Humana is investing a total of $125,000 in the Humana Scholars program, which includes two components – a Scholarship Fund and a Student Support Fund – to help train and support a pipeline of skilled nurses. The program will offer both scholarships and help reduce barriers, like food insecurity or lack of transportation, for f

    2/5/26 10:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Report Finds Value-Based Care Improves Outcomes for Medicare Advantage Members

    Medicare Advantage members in value-based care arrangements had 24.3% fewer inpatient hospital admissions than those in Original Medicare in 2024. Humana Medicare Advantage members receiving value-based care had 13.4% fewer emergency department visits and 7.6% fewer hospital admissions than members in non-value-based care arrangements. Medicare Advantage members receiving value-based care reported higher satisfaction with their care, including a 13-point higher Net Promoter Score than those using fee-for-service. Humana Inc. (NYSE:HUM), a health and well-being company focused on helping people live their healthiest lives, today released its latest Value-Based Care By the Numbers

    2/4/26 8:45:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Rechtin James A. bought $1,496,984 worth of Humana Common (6,530 units at $229.25) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    5/16/25 4:48:13 PM ET
    $HUM
    Medical Specialities
    Health Care

    Mesquita Jorge S. bought $200,066 worth of Humana Common (545 units at $367.09) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/21/24 10:37:23 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Leadership Updates

    Live Leadership Updates

    View All

    Humana Announces Insurance Leadership Transition

    George Renaudin to Retire as Insurance Segment President by Q3 2026 Aaron Martin to Join as President of Medicare Advantage and Insurance Segment President Successor John Barger to Succeed Martin as President of Medicare Advantage Humana Inc. (NYSE:HUM) today announced that George Renaudin, Insurance Segment President and member of Humana's Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana's Medicare Advantage and Medicaid programs, helping to build them into high-performing businesses and assembling a strong insurance leadership team. "George has co

    12/16/25 8:05:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    National Mall of Pickleball Returns for Third Year with Expanded Footprint and New, Central Location

    The National Mall of Pickleball will celebrate America's most accessible sport and the game that serves all in the heart of the National Mall this September The Trust for the National Mall, Humana (NYSE:HUM), and the Humana Foundation announced today that the highly-anticipated National Mall of Pickleball is returning to America's Front Yard, the National Mall, for a third year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625316935/en/ From Friday, September 19 through Sunday, September 21, 2025, the general public can experience a weekend full of pickleball programming, activities, and community with captivating views o

    6/25/25 9:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Launches "Invite" Campaign to Inspire Active Aging Through Pickleball and Community Connection

    Humana Inc. (NYSE:HUM), a leading health and well-being company, is expanding its commitment to senior wellness with the launch of Invite, a new campaign designed to encourage older adults of all fitness levels to stay active, connected and engaged – starting with the fastest-growing sport in America: pickleball. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618737488/en/As part of Humana's new "Invite" campaign, the health and wellness company debuted a television spot featuring senior pickleball athletes extending an open invitation to others to join the fun, stay social, and support their physical and mental well-being. A

    6/18/25 8:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Financials

    Live finance-specific insights

    View All

    Humana Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Financial Guidance

    Reports 4Q25 net loss per share of $6.61 on a GAAP basis, Adjusted net loss per share of $3.96; reports full year (FY) 2025 earnings per share (EPS) of $9.84 on a GAAP basis, $17.14 on an Adjusted basis; quarterly and FY Adjusted results in line with management's expectations 4Q25 Insurance segment GAAP benefit ratio of 93.1 percent; FY 2025 Insurance segment GAAP benefit ratio of 90.4 percent, slightly better than guidance of 'the top end of the range of 90.1 percent to 90.5 percent' Introduces FY 2026 GAAP EPS guidance of 'at least $8.89'; 'at least $9.00' on an Adjusted basis; the anticipated year-over-year decline results from the Star Ratings headwind for Bonus Year 2026, net of

    2/11/26 6:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Inc. to Release Fourth Quarter 2025 Results on February 11, 2026

    Humana Inc. (NYSE:HUM) will release its financial results for the fourth quarter 2025 (4Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on February 11, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 4Q25 earnings call may be accessed via Humana's Investor Relations page at https://humana.gcs-web.com/. If you anticipate asking a question during the question-and-answer session, please register in advance using this link, https://register-conf.media-server.com/register/BIb3f01f81dd3b4f7cb8331d38dad89

    1/9/26 6:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    AM Best Affirms Credit Ratings of Humana Inc. and Its Subsidiaries

    AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) for the health and dental insurance subsidiaries of Humana Inc. (Humana) (headquartered in Louisville, KY) (NYSE:HUM). These subsidiaries collectively are referred to as Humana Health Group. In addition, AM Best has affirmed the Long-Term ICR of "bbb" (Good) and the Long-Term Issue Credit Ratings (Long-Term IRs) of Humana Inc. (Humana). AM Best also has affirmed the Short-Term Issue Credit Rating of AMB-2 (Satisfactory) for Humana. The outlook of these Credit Ratings (ratings) is stable. (See below for a detailed listing of Humana Health Group

    12/16/25 5:31:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/16/24 4:29:43 PM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/14/24 10:02:59 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/13/24 5:06:27 PM ET
    $HUM
    Medical Specialities
    Health Care